{"id":769643,"date":"2023-07-13T10:49:51","date_gmt":"2023-07-13T14:49:51","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\/"},"modified":"2023-07-13T10:49:51","modified_gmt":"2023-07-13T14:49:51","slug":"maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\/","title":{"rendered":"MaxCyte to Report Second Quarter 2023 Financial Results on August 9, 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p>ROCKVILLE, Md., July  13, 2023  (GLOBE NEWSWIRE) &#8212; MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support innovative cell-based research, today announced that it will release financial results for the second quarter 2023 after the U.S. market close on Wednesday, August 9<sup>th<\/sup>, 2023. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time.<\/p>\n<p>\n        <strong>Earnings Conference Call Details<\/strong><br \/>\n        <br \/>Investors interested in listening to the conference call are required to <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tfld_LAr239kb-k8hGWL9J9hGas9i_nP1Zjn8MBrA6BmuSDl36LLbnzWi6MWx8eAAaXl8-4Im7OMFZFiMNU4TdktMb-K1CDcnC3LarBfeTwoTnDzpHj8w46xuaZ50sMuqd3758HsrQbpjDi2UPMKCQ==\" rel=\"nofollow noopener\" target=\"_blank\">register online<\/a>. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the \u201cEvents\u201d section of the MaxCyte website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_7G6XGnFlXIai91ziOt3LYtBHDqP9GBZZCFTrSQKda3X7kcAq72NNQJxylZKhJ5fieyjCFUY2zOokpFAln8Uixr8VS0_QtHY6PTwPYmum-s9wHNR9a57Sp4FKAeXk0St\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/investors.maxcyte.com\/<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About MaxCyte<\/strong><br \/>\n        <br \/>At MaxCyte, we pursue cell engineering excellence to maximize the potential of cells to improve patients\u2019 lives. We have spent more than 20 years honing our expertise by building best-in-class platforms, perfecting the art of the transfection workflow, and venturing beyond today\u2019s processes to innovate tomorrow\u2019s solutions. Our ExPERT\u2122 platform, which is based on our Flow Electroporation<em>\u00ae<\/em> technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes: four instruments, the ATx\u2122, STx\u2122, GTx\u2122 and VLx \u2122; a portfolio of proprietary related processing assemblies or disposables; and software protocols, all supported by a robust worldwide intellectual property portfolio. By providing our partners with the right technology, as well as technical and regulatory support, we aim to guide them on their journey to transform human health. Learn more at maxcyte.com and follow us on Twitter and LinkedIn.<\/p>\n<p align=\"justify\">\n        <strong>MaxCyte Contacts:<\/strong>\n      <\/p>\n<p>\n        <strong><br \/>\n          <em>US IR Adviser<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>\n        <strong><br \/>\n          <em>Gilmartin Group<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>David Deuchler, CFA<br \/>+1 415-937-5400<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ej8qCPhRFooBTnU9luqR-dsv7zzxgH9mzt_tmIirTzSzcrKfcdUf6T_6-fqsokp58ST7XqSsvzNlzYgx9hgGEg==\" rel=\"nofollow noopener\" target=\"_blank\">ir@maxcyte.com<\/a><\/p>\n<p>\n        <strong><br \/>\n          <em>Nominated Adviser and Joint Corporate Broker<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>\n        <strong><br \/>\n          <em>Panmure Gordon<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>Emma Earl \/ Freddy Crossley<br \/>Corporate Broking<br \/>Rupert Dearden<br \/>+44 (0)20 7886 2500<\/p>\n<p>\n        <strong><br \/>\n          <em>UK IR Adviser<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>\n        <strong><br \/>\n          <em>Consilium Strategic Communications<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>Mary-Jane Elliott \/ Chris Welsh<br \/>+44 (0)203 709 5700<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gZ1SPNiSRdyldYObTrNm5r2pws2TrhWQAuky57GGVrc1HYzPrpuxWVu_AGuOfI6YkCkBw2r4fEfmmX6FKVDaly8fb2qUl2cQrjXpUhCMkFZC8knaJIU86TTkarkyG9H6\" rel=\"nofollow noopener\" target=\"_blank\"><u>maxcyte@consilium-comms.com<\/u><\/a><\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MzY2NSM1Njg3Njk0IzIyMDUxNzg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZWQ5ODZkMDYtMzE2YS00Njg1LTk0ZTQtNDA4YzU1NzZhNjM0LTEyMTY3MzE=\/tiny\/MaxCyte-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ROCKVILLE, Md., July 13, 2023 (GLOBE NEWSWIRE) &#8212; MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support innovative cell-based research, today announced that it will release financial results for the second quarter 2023 after the U.S. market close on Wednesday, August 9th, 2023. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time. Earnings Conference Call Details Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;MaxCyte to Report Second Quarter 2023 Financial Results on August 9, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-769643","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MaxCyte to Report Second Quarter 2023 Financial Results on August 9, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MaxCyte to Report Second Quarter 2023 Financial Results on August 9, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ROCKVILLE, Md., July 13, 2023 (GLOBE NEWSWIRE) &#8212; MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support innovative cell-based research, today announced that it will release financial results for the second quarter 2023 after the U.S. market close on Wednesday, August 9th, 2023. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time. Earnings Conference Call Details Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the &hellip; Continue reading &quot;MaxCyte to Report Second Quarter 2023 Financial Results on August 9, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-13T14:49:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MzY2NSM1Njg3Njk0IzIyMDUxNzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MaxCyte to Report Second Quarter 2023 Financial Results on August 9, 2023\",\"datePublished\":\"2023-07-13T14:49:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\\\/\"},\"wordCount\":348,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3MzY2NSM1Njg3Njk0IzIyMDUxNzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\\\/\",\"name\":\"MaxCyte to Report Second Quarter 2023 Financial Results on August 9, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3MzY2NSM1Njg3Njk0IzIyMDUxNzg=\",\"datePublished\":\"2023-07-13T14:49:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3MzY2NSM1Njg3Njk0IzIyMDUxNzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3MzY2NSM1Njg3Njk0IzIyMDUxNzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MaxCyte to Report Second Quarter 2023 Financial Results on August 9, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MaxCyte to Report Second Quarter 2023 Financial Results on August 9, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\/","og_locale":"en_US","og_type":"article","og_title":"MaxCyte to Report Second Quarter 2023 Financial Results on August 9, 2023 - Market Newsdesk","og_description":"ROCKVILLE, Md., July 13, 2023 (GLOBE NEWSWIRE) &#8212; MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support innovative cell-based research, today announced that it will release financial results for the second quarter 2023 after the U.S. market close on Wednesday, August 9th, 2023. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time. Earnings Conference Call Details Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the &hellip; Continue reading \"MaxCyte to Report Second Quarter 2023 Financial Results on August 9, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-07-13T14:49:51+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MzY2NSM1Njg3Njk0IzIyMDUxNzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MaxCyte to Report Second Quarter 2023 Financial Results on August 9, 2023","datePublished":"2023-07-13T14:49:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\/"},"wordCount":348,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MzY2NSM1Njg3Njk0IzIyMDUxNzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\/","name":"MaxCyte to Report Second Quarter 2023 Financial Results on August 9, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MzY2NSM1Njg3Njk0IzIyMDUxNzg=","datePublished":"2023-07-13T14:49:51+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MzY2NSM1Njg3Njk0IzIyMDUxNzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MzY2NSM1Njg3Njk0IzIyMDUxNzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2023-financial-results-on-august-9-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MaxCyte to Report Second Quarter 2023 Financial Results on August 9, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/769643","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=769643"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/769643\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=769643"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=769643"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=769643"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}